Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510000, China
Location status: Recruiting
NCT Number: NCT07594704
This prospective randomized controlled trial compares the effectiveness and safety of one-needle and two-needle tunneling techniques for peripherally inserted central catheter (PICC) placement, aiming to identify the optimal tunneling method to reduce catheter-related complications.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510000, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two-needle tunnel PICC procedure:
Time frame: 4 weeks after PICC placement
these complications include catheter exit site oozing, contact dermatitis, venous thrombosis, infection, catheter displacement or dislodgement, mechanical phlebitis, catheter occlusion, and catheter fracture or damage.
Time frame: day 1 during PICC catheterization
Time frame: Day 1 during PICC placement
Evaluated by Numerical Rating Scale , a self-report tool where individuals rate their pain intensity from 0 (no pain) to 10 (worst possible pain),with higher scores indicating more severe pain.
Time frame: Day 1 during PICC placement
Time frame: 4 weeks after PICC placement
Contact information is provided by the study sponsor or research team.
Sun Yat-sen University
Other
Effects of Different Tunnel Methods in PICC Catheterization: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03017911
Cardiovascular Diseases, Embolism and Thrombosis
Brest, France
View Trial DetailsNCT06979128
PICC Line Placement, Vascular Access
Warsaw, Poland
View Trial DetailsNCT07466472
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
View Trial DetailsNCT07175428
Arrhythmias, Cardiac, Atrial Fibrillation
Dothan, Alabama, United States
View Trial Details